bromocriptine has been researched along with Hyperlipidemias in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawakami, K; Matsubayashi, K | 1 |
| Christensen, NC; Hagen, C; Nielsen, MD; Petersen, S | 1 |
| Cvak, L; Golda, V | 1 |
| Cincotta, AH; Liang, Y; Lubkin, M; Scislowski, PW; Sheng, H | 1 |
| Cincotta, AH; Phaneuf, S; Prevelige, R; Scislowski, PW; Zhang, Y | 1 |
5 other study(ies) available for bromocriptine and Hyperlipidemias
| Article | Year |
|---|---|
Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Comorbidity; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Incidence; Japan; Male; Middle Aged; Neurosurgical Procedures; Octreotide; Peptides, Cyclic; Prevalence; Radiosurgery; Radiotherapy, Intensity-Modulated; Retrospective Studies; Somatostatin; Young Adult | 2020 |
Hypernatraemia, diabetes mellitus, hyperprolactinaemia, retarded growth and delayed puberty in a 14 year old girl. Effect of bromocriptine treatment.
Topics: Adolescent; Bromocriptine; Diabetes Mellitus, Type 1; Estradiol; Female; Gonadotropins, Pituitary; Growth Disorders; Humans; Hydrocortisone; Hyperlipidemias; Hypernatremia; Pituitary Function Tests; Prolactin; Puberty, Delayed; Renin | 1981 |
Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
Topics: Animals; Blood Pressure; Body Weight; Bromocriptine; Disease Models, Animal; Female; Glucose Intolerance; Hyperlipidemias; Hypertension; Insulin; Lipids; Lisuride; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Sex Factors | 1994 |
Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Glucose; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Agonists; Glucokinase; Glucose; Hexokinase; Hyperglycemia; Hyperlipidemias; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Lipids; Mice; Mice, Inbred C57BL; Mice, Obese; Protein Kinase C; Tetradecanoylphorbol Acetate | 1998 |
Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Bromocriptine; Dopamine Agonists; Drug Synergism; Drug Therapy, Combination; Female; Hyperlipidemias; Lipolysis; Lipoproteins; Mice; Mice, Obese; Receptors, Dopamine; Triglycerides | 1999 |